BCL6 controls the expression of the B7-1/CD80 costimulatory receptor in germinal center B cells

Journal of Experimental Medicine

Volumn 198, Issue 2, 2003, Pages 211-221

  Niu, Huifeng ^a   Cattoretti, Giorgio ^a   Dalla Favera, Riccardo ^a  

^a Teachers College   (United States)

Author keywords

BCL6; CD40; CD80; Germinal center; Lymphoma

Indexed keywords

B7 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR FACTOR; PROTEIN BCL 6;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CELL INTERACTION; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; GERMINAL CENTER; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSCRIPTION INITIATION;

ANTIGENS, CD; ANTIGENS, CD80; B-LYMPHOCYTES; BASE SEQUENCE; BURKITT LYMPHOMA; CELL LINE; DNA-BINDING PROTEINS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC VECTORS; GERM-LINE MUTATION; HUMANS; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-6; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; ZINC FINGERS;

EID: 0042161855     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20021395     Document Type: Article

References (48)

1. Ye, B.H., P.H. Rao, R.S. Chaganti, and R. Dalla-Favera. 1993. Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma. Cancer Res. 53:2732-2735.
2. Baron, B.W., G. Nucifora, N. McCabe, R.D. Espinosa, M.M. Le Beau, and T.W. McKeithan. 1993. Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas. Proc. Natl. Acad. Sci. USA. 90:5262-5266.
3. Kerckaert, J.P., C. Deweindt, H. Tilly, S. Quief, G. Lecocq, and C. Bastard. 1993. LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nat. Genet. 5:66-70.
4. Miki, T., N. Kawamata, S. Hirosawa, and N. Aoki. 1994. Gene involved in the 3q27 translocation associated with B-cell lymphoma, BCL5, encodes a Kruppel-like zinc-finger protein. Blood. 83:26-32.
5. Lo Coco, F., B.H. Ye, F. Lista, P. Corradini, K. Offit, D.M. Knowles, R.S. Chaganti, and R. Dalla-Favera. 1994. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood. 83:1757-1759.
6. Ye, B.H., F. Lista, F. Lo Coco, D.M. Knowles, K. Offit, R.S. Chaganti, and R. Dalla-Favera. 1993. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science. 262:747-750.
7. Collins, T., J.R. Stone, and A.J. Williams. 2001. All in the family: the BTB/POZ, KRAB, and SCAN domains. Mol. Cell. Biol. 21:3609-3615.
8. Chang, C.C., B.H. Ye, R.S. Chaganti, and R. Dalla-Favera. 1996. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc. Natl. Acad. Sci. USA. 93:6947-6952.
9. Seyfert, V.L., D. Allman, Y. He, and L.M. Staudt. 1996. Transcriptional repression by the proto-oncogene BCL-6. Oncogene. 12:2331-2342.
10. Wong, C.W., and M.L. Privalsky. 1998. Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6. J. Biol. Chem. 273:27695-27702.
11. Dhordain, P., R.J. Lin, S. Quief, D. Lantoine, J.P. Kerckaert, R.M. Evans, and O. Albagli. 1998. The LAZ3(BCL-6) on-coprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression. Nucleic Acids Res. 26:4645-4651.
12. Deltour, S., C. Guerardel, and D. Leprince. 1999. Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B. Proc. Natl. Acad. Sci. USA. 96:14831-14836.
13. Cattoretti, G., C.C. Chang, K. Cechova, J. Zhang, B.H. Ye, B. Falini, D.C. Louie, K. Offit, R.S. Chaganti, and R. Dalla-Favera. 1995. BCL-6 protein is expressed in germinal-center B cells. Blood. 86:45-53.
14. Allman, D., A. Jain, A. Dent, R.R. Maile, T. Selvaggi, M.R. Kehry, and L.M. Staudt. 1996. BCL-6 expression during B-cell activation. Blood. 87:5257-5268.
15. Onizuka, T., M. Moriyama, T. Yamochi, T. Kuroda, A. Kazama, N. Kanazawa, K. Sato, T. Kato, H. Ota, and S. Mori. 1995. BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. Blood. 86:28-37.
16. Dent, A.L., A.L. Shaffer, X. Yu, D. Allman, and L.M. Staudt. 1997. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science. 276:589-592.
17. Ye, B.H., G. Cattoretti, Q. Shen, J. Zhang, N. Hawe, R. de Waard, C. Leung, M. Nouri-Shirazi, A. Orazi, R.S. Chaganti, et al. 1997. The BCL-6 proto-oncogene controls germinal-centre formation and Th2- type inflammation. Nat. Genet. 16:161-170.
18. Niu, H., B.H. Ye, and R. Dalla-Favera. 1998. Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor. Genes Dev. 12:1953-1961.
19. Ye, B.H., S. Chaganti, C.C. Chang, H. Niu, P. Corradini, R.S. Chaganti, and R. Dalla-Favera. 1995. Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. EMBO J. 14:6209-6217.
20. Migliazza, A., S. Martinotti, W. Chen, C. Fusco, B.H. Ye, D.M. Knowles, K. Offit, R.S. Chaganti, and R. Dalla-Favera. 1995. Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma. Proc. Natl. Acad. Sci. USA. 92:12520-12524.
21. Pasqualucci, L., A. Migliazza, N. Fracchiolla, C. William, A. Neri, L. Baldini, R.S. Chaganti, U. Klein, R. Kuppers, K. Rajewsky, and R. Dalla-Favera. 1998. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc. Natl. Acad. Sci. USA. 95:11816-11821.
22. Peng, H.Z., M.Q. Du, A. Koulis, A. Aiello, A. Dogan, L.X. Pan, and P.G. Isaacson. 1999. Nonimmunoglobulin gene hypermutation in germinal center B cells. Blood. 93:2167-2172.
23. Shen, H.M., A. Peters, B. Baron, X. Zhu, and U. Storb. 1998. Mutation of BCL-6 gene in normal B cells by the process of somatic hypennutation of Ig genes. Science. 280:1750-1752.
24. Artiga, M.J., A.I. Saez, C. Romero, M. Sanchez-Beato, M.S. Mateo, C. Navas, M. Mollejo, and M.A. Piris. 2002. A short mutational hot spot in the first intron of BCL-6 is associated with increased BCL-6 expression and with longer overall survival in large B-cell lymphomas. Am. J. Pathol. 160:1371-1380.
25. Harris, M.B., C.C. Chang, M.T. Berton, N.N. Danial, J. Zhang, D. Kuehner, B.H. Ye, M. Kvatyuk, P.P. Pandolfi, G. Cattoretti, et al. 1999. Transcriptional repression of Stat6-dependent interleukin-4-induced genes by BCL-6: specific regulation of iepsilon transcription and immunoglobulin E switching. Mol. Cell. Biol. 19:7264-7275.
26. Baron, B.W., J. Anastasi, M.J. Thirman, Y. Furukawa, S. Fears, D.C. Kim, F. Simone, M. Birkenbach, A. Montag, A. Sadhu, et al. 2002. The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis. Proc. Natl. Acad. Sci. USA. 99:2860-2865.
27. Hosokawa, Y., Y. Maeda, and M. Seto. 2001. Target genes downregulated by the BCL-6/LAZ3 oncoprotein in mouse Ba/F3 cells. Biochem. Biophys. Res. Commun. 283:563-568.
28. Shaffer, A.L., X. Yu, Y. He, J. Boldrick, E.P. Chan, and L.M. Staudt. 2000. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity. 13:199-212.
29. Borriello, F., M.P. Sethna, S.D. Boyd, A.N. Schweitzer, E.A. Tivol, D. Jacoby, T.B. Strom, E.M. Simpson, G.J. Freeman, and A.H. Sharpe. 1997. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity. 6:303-313.
30. Lenschow, D.J., Y. Zeng, J.R. Thistlethwaite, A. Montag, W. Brady, M.G. Gibson, P.S. Linsley, and J.A. Bluestone. 1992. Long-tenn survival of xenogeneic pancreatic islet grafts induced by CTLA41g. Science. 257:789-792.
31. Turka, L.A., P.S. Linsley, H. Lin, W. Brady, J.M. Leiden, R.Q. Wei, M.L, Gibson, X.G. Zheng, S. Myrdal, D. Gordon, et al. 1992. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA. 89:11102-11105.
32. Dorfman, D.M., J.L. Schultze, A. Shahsafaei, S. Michalak, J.G. Gribben, G.J. Freeman, G.S. Pinkus, and L.M. Nadler. 1997. In vivo expression of B7-1 and B7-2 by follicular lymphoma cells can prevent induction of T-cell anergy but is insufficient to induce significant T-cell proliferation. Blood. 90:4297-4306.
33. Liu, Y.J., C. Barthelemy, O. de Bouteiller, C. Arpin, I. Durand, and J. Banchereau. 1995. Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-1 and B7-2. Immunity. 2:239-248.
34. Grignani, F., T. Kinsella, A. Mencarelli, M. Valtieri, D. Riganelli, L. Lanfrancone, C. Peschle, G.P. Nolan, and P.G. Pelicci. 1998. High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res. 58:14-19.
35. Zhao, J., G.J. Freeman, G.S. Gray, L.M. Nadler, and L.H. Glimcher. 1996. A cell type-specific enhancer in the human B7.1 gene regulated by NF- kappaB. J. Exp. Med. 183:777-789.
36. Clark, L.B., T.M. Foy, and R.J. Noelle. 1996. CD40 and its ligand. Adv. Immunol. 63:43-78.
37. Lederman, S., A.M. Cleary, M.J. Yellin, D.M. Frank, M. Karpusas, D.W. Thomas, and L. Chess. 1996. The central role of the CD40-ligand and CD40 pathway in T-lymphocyte-mediated differentiation of B lymphocytes. Curr. Opin. Hematol. 3:77-86.
38. Lalmanach-Girard, A.C., T.C. Chiles, D.C. Parker, and T.L. Rothstein. 1993. T cell-dependent induction of NF-kappa B in B cells. J. Exp. Med. 177:1215-1219.
39. Berberich, I., G.L. Shu, and E.A. Clark. 1994. Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B.J. Immunol. 153:4357-4366.
40. Rowe, M., D.T. Rowe, C.D. Gregory, L.S. Young, P.J. Farrell, H. Rupani, and A.B. Rickinson. 1987. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J. 6:2743-2751.
41. Rowe, M., R. Khanna, C.A. Jacob, V. Argaet, A. Kelly, S. Powis, M. Belich, D. Croom-Carter, S. Lee, S.R. Burrows, et al. 1995. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Eur. J. Immunol. 25:1374-1384.
42. Pasqualucci, L. M.A., Basso K, Houldsworth J, Chaganti RS, Dalla-Favera R. 2003. Mutations of the BCL-6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. Blood. 101:2914-2923.
43. Wang X, Z. Li, A. Naganuma, and B.H. Ye. 2002. Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B cell lymphomas. Proc. Natl. Acad. Sci. USA. 99:15018-15023.
44. Messner, B., A.M. Stutz, B. Albrecht, S. Peiritsch, and M. Woisetschlager. 1997. Cooperation of binding sites for STAT6 and NF kappa B/rel in the IL-4-induced up-regulation of the human IgE germline promoter. J. Immunol. 159:3330-3337.
45. Hsing, Y., and G.A. Bishop. 1999. Requirement for nuclear factor-kappaB activation by a distinct subset of CD40-mediated effector functions in B lymphocytes. J. Immunol. 162:2804-2811.
46. Freeman, G.J., V.A. Boussiotis, A. Anumanthan, G.M. Bernstein, X.Y. Ke, P.D. Rennert, G.S. Gray, J.G. Gribben, and L.M. Nadler. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity. 2:523-532.
47. Natarajan, K., N.C. Sahoo, and K.V. Rao. 2001. Signal thresholds and modular synergy during expression of costimulatory molecules in B lymphocytes. J. Immunol. 167:114-122.
48. Butler, M.P., S. Iida, D. Capello, D. Rossi, P.H. Rao, P. Nallasivam, D.C. Louie, S. Chaganti, T. Au, R.D. Gascoyne, et al. 2002. Alternative translocation breakpoint cluster region 5′ to BCL-6 in B-cell non-Hodgkin's lymphoma. Cancer Res. 62:4089-4094.